[ad_1] McKesson slips as Q2 outlook underwhelms [ad_2] Source: Seekingalpha
Browsing: Healthcare
[ad_1] Perspective gets FDA fast track status for radiopharmaceutical VMT01 [ad_2] Source: Seekingalpha
[ad_1] Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket [ad_2] Source: Seekingalpha
[ad_1] lcodacci Genetic Leap, an organization targeted on AI-driven drug discovery, introduced Thursday a analysis collaboration price as much as $409M with Eli Lilly (NYSE:LLY) to…
[ad_1] Lisata jumps on FDA orphan drug status for liver cancer drug [ad_2] Source: Seekingalpha
[ad_1] Ascendis raised to outperform by Oppenheimer ahead of drug launch [ad_2] Source: Seekingalpha
[ad_1] Vor Bio stock rallies post-market on trem-cel study data [ad_2] Source: Seekingalpha
[ad_1] aTyr started at buy by Jefferies, citing efzofitimod potential [ad_2] Source: Seekingalpha
[ad_1] Kits Eyecare (TSX:KITS:CA) mentioned on Thursday that sure promoting shareholders have entered into an settlement with Canaccord Genuity as sole bookrunner to buy on a…
[ad_1] Ensysce Biosciences announces $5M concurrent providing, shares fall [ad_2] Source: Seekingalpha
